Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Clinical Biochemistry
|
May 21, 2008
Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects
Guoxin Wu, Sethu Sankaranarayanan, Kate Tugusheva, et al.
Journal of Biomolecular Screening
|
May 16, 2012
Minimum significant ratio of selectivity ratios (MSRSR) and confidence in ratio of selectivity ratios (CRSR): quantitative measures for selectivity ratios obtained by screening assays
Eric R Goedken, Viswanath Devanarayan, Christopher M Harris, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
December 14, 2011
Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease
Annika Ohrfelt, Ulf Andreasson, Adam Simon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 13, 2023
Predicting clinical progression trajectories of early Alzheimer's disease patients
Viswanath Devanarayan, Yuanqing Ye, Arnaud Charil, et al.
The AAPS Journal
|
September 18, 2015
Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development
Darshana Jani, John Allinson, Flora Berisha, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Viswanath Devanarayan, Yuanqing Ye, Michael C Donohue, et al.
The American Journal of Pathology
|
October 28, 2003
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells
Janardhan Sampath, Pandy R Long, Robert L Shepard, et al.
The AAPS Journal
|
April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment
Marian Kelley, Lauren Stevenson, Michaela Golob, et al.
Molecular Cancer Therapeutics
|
February 25, 2010
Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines
Stephen K Tahir, John Wass, Mary K Joseph, et al.
Alzheimer'S Research & Therapy
|
December 7, 2023
The age-specific comorbidity burden of mild cognitive impairment: a US claims database study
Gang Li, Nicola Toschi, Viswanath Devanarayan, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Clinical Biochemistry
|
May 21, 2008
Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects
Guoxin Wu, Sethu Sankaranarayanan, Kate Tugusheva, et al.
Journal of Biomolecular Screening
|
May 16, 2012
Minimum significant ratio of selectivity ratios (MSRSR) and confidence in ratio of selectivity ratios (CRSR): quantitative measures for selectivity ratios obtained by screening assays
Eric R Goedken, Viswanath Devanarayan, Christopher M Harris, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
December 14, 2011
Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease
Annika Ohrfelt, Ulf Andreasson, Adam Simon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 13, 2023
Predicting clinical progression trajectories of early Alzheimer's disease patients
Viswanath Devanarayan, Yuanqing Ye, Arnaud Charil, et al.
The AAPS Journal
|
September 18, 2015
Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development
Darshana Jani, John Allinson, Flora Berisha, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Viswanath Devanarayan, Yuanqing Ye, Michael C Donohue, et al.
The American Journal of Pathology
|
October 28, 2003
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells
Janardhan Sampath, Pandy R Long, Robert L Shepard, et al.
The AAPS Journal
|
April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment
Marian Kelley, Lauren Stevenson, Michaela Golob, et al.
Molecular Cancer Therapeutics
|
February 25, 2010
Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines
Stephen K Tahir, John Wass, Mary K Joseph, et al.
Alzheimer'S Research & Therapy
|
December 7, 2023
The age-specific comorbidity burden of mild cognitive impairment: a US claims database study
Gang Li, Nicola Toschi, Viswanath Devanarayan, et al.
Page
of 7